Elad Sharon: New framework to consider phase 1 clinical trials ⁦

Elad Sharon, Medical Oncologist at Dana-Farber, shared on X:

“Nagla Abdel Karim gives us a new framework to consider phase 1 clinical trials ⁦

Inova Health⁩’s Evolving Therapies meeting!”